Walgreens Boosts Alliance (WBA) PT Lowered to $52 at Deutsche Bank

Walgreens Boosts Alliance (WBA) PT Lowered to $52 at Truist Securities

Truist Securities analyst David MacDonald lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $52.00 (from $58.00) while maintaining a Hold rating following earnings.

The analyst commented, "WBA reported F3Q results that were ahead of expectations and raised FY21EPS guidance.... More

Walgreens Boosts Alliance (WBA) PT Lowered to $48 at Credit Suisse

Credit Suisse analyst A.J. Rice lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $48.00 (from $50.00) while maintaining a Neutral rating.

Walgreens Boots Alliance (WBA) Is Not Standing Still - BTIG

BTIG analyst, David Larsen, wrote up the earnings note for Walgreens Boots Alliance (NASDAQ: WBA) despite not having a formal rating. Despite shares trading down, he is generally impressed with the amount of attention and effort that seems to be getting put into the firm's... More

Walgreens Boosts Alliance (WBA) PT Lowered to $68 at Baird

Baird analyst Eric Coldwell lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $68.00 (from $72.00) while maintaining an Outperform rating.

The analyst commented, "Despite the strong beat, positive core trends, and update on strategic initiatives, market is hung up... More

Walgreens Boots Alliance (WBA) call put ratio 2.6 calls to 1 put

Walgreens Boots Alliance (NASDAQ: WBA) call put ratio 2.6 calls to 1 put

Walgreens expects lower COVID-19 vaccinations in Q4, shares fall

By Mrinalika Roy and Amruta Khandekar

(Reuters) -Walgreens Boots Alliance Inc said on Thursday it expects to administer fewer COVID-19 vaccines in the fourth quarter after inoculations peaked in the previous quarter, sending its shares down nearly 7%.

Walgreens had been relying on gains from administering COVID-19 vaccines to tide over losses from low prescription volumes and a weak flu season that has hampered over-the-counter sales of health and wellness... More

Walgreens Boots Alliance (WBA) Tops Q3 EPS by 37c

Walgreens Boots Alliance (NASDAQ: WBA) reported Q3 EPS of $1.51, $0.37 better than the analyst estimate of $1.14. Revenue for the quarter came in at $34 billion versus the consensus estimate of $33.69 billion.

Company Outlook:

The company raised fiscal 2021 guidance from mid-to-high single... More